These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6882883)

  • 41. Absorption-dependent apparent volume of distribution at steady state (V(ss)/F) in pharmacokinetic data analysis.
    Soback S; Britzi M
    J Vet Pharmacol Ther; 2011 Oct; 34(5):512-4. PubMed ID: 21906082
    [No Abstract]   [Full Text] [Related]  

  • 42. The Universally Unrecognized Assumption in Predicting Drug Clearance and Organ Extraction Ratio.
    Benet LZ; Liu S; Wolfe AR
    Clin Pharmacol Ther; 2018 Mar; 103(3):521-525. PubMed ID: 28762489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug dosage in renal disease.
    Dettli L
    Clin Pharmacokinet; 1976; 1(2):126-34. PubMed ID: 797495
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug and metabolite concentrations combined in predicting steady-state concentrations from test doses.
    Devane CL; Jusko WJ
    Biopharm Drug Dispos; 1983; 4(1):19-29. PubMed ID: 6839000
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Noncompartmental determination of the steady-state volume of distribution.
    Benet LZ; Galeazzi RL
    J Pharm Sci; 1979 Aug; 68(8):1071-4. PubMed ID: 480170
    [No Abstract]   [Full Text] [Related]  

  • 46. Conceptual underestimation of the total body clearance by the sum of clearances of individual organs in physiologically based pharmacokinetics.
    Berezhkovskiy LM
    J Pharm Sci; 2012 Dec; 101(12):4660-5. PubMed ID: 23001916
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The physiological significance of the apparent volume of distribution, Vdarea or Vd beta, in pharmacokinetic studies.
    Chiou WL
    Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):499-508. PubMed ID: 7330454
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Theoretic aspects of pharmacokinetic drug interactions.
    Gillette JR; Pang KS
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 2):623-39. PubMed ID: 913029
    [No Abstract]   [Full Text] [Related]  

  • 49. A dispersion model of hepatic elimination: 3. Application to metabolite formation and elimination kinetics.
    Roberts MS; Rowland M
    J Pharmacokinet Biopharm; 1986 Jun; 14(3):289-308. PubMed ID: 3783448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Simple model to explain effects of plasma protein binding and tissue binding on calculated volumes of distribution, apparent elimination rate constants and clearances.
    Wagner JG
    Eur J Clin Pharmacol; 1976; 10(6):425-32. PubMed ID: 1001358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Model independent derivation of general equations for the "first-pass" effect and extra-hepatic drug elimination.
    Vaughan
    Eur J Clin Pharmacol; 1977; 11(1):57-64. PubMed ID: 832659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. General method for evaluating the fraction of the irreversible organ clearance due to conversion of drug to a primary metabolite.
    Bayne WF; Hwang SS
    J Pharm Sci; 1985 Jul; 74(7):722-6. PubMed ID: 4032242
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estimation of absolute bioavailability assuming steady state apparent volume of distribution remains constant.
    Collier PS; Riegelman S
    J Pharmacokinet Biopharm; 1983 Apr; 11(2):205-14. PubMed ID: 6886975
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of Clearance, Volume of distribution, and Half-life of Drugs in Extremely Low to Low Birth Weight Neonates: An Allometric Approach.
    Mahmood I
    Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):601-610. PubMed ID: 27562171
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The use of the concepts of "half-life" and "clearance" in practice and in pharmacokinetics].
    Raaflaub J
    Schweiz Med Wochenschr; 1981 Sep; 111(38):1406-11. PubMed ID: 7280641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single pass mean residence time in peripheral tissues: a distribution parameter intrinsic to the tissue affinity of a drug.
    Veng-Pedersen P; Gillespie WR
    J Pharm Sci; 1986 Dec; 75(12):1119-26. PubMed ID: 3559920
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Noncompartmental determination of the steady-state volume of distribution during multiple dosing.
    Smith IL; Schentag JJ
    J Pharm Sci; 1984 Feb; 73(2):281-2. PubMed ID: 6707904
    [No Abstract]   [Full Text] [Related]  

  • 58. [Mean residence time in the body. A new pharmacokinetic parameter?].
    Taburet AM; Steimer JL; Doucet D; Singlas E
    Therapie; 1986; 41(1):1-10. PubMed ID: 3704987
    [No Abstract]   [Full Text] [Related]  

  • 59. [Influence of plasma and tissue protein binding on the apparent volume of distribution of drugs].
    Houin G; Barre J; Tillement JP
    Therapie; 1984; 39(3):247-51. PubMed ID: 6463952
    [No Abstract]   [Full Text] [Related]  

  • 60. Application of queueing theory to pharmacokinetics.
    Brill PH; Moon RE
    J Pharm Sci; 1980 May; 69(5):558-60. PubMed ID: 7381743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.